Rock Springs Capital Management LP Q3 2019 Filing

Filed November 14, 2019

Portfolio Value

$2.5T

Holdings

138

Report Date

Q3 2019

Filing Type

13F-HR

All Holdings (138 positions)

StockValue
MOMENTA PHARMACEUTICALS INC
$5.2M
AKROAKERO THERAPEUTICS INC
$5.1M
$5.0M
DERMIRA INC
$5.0M
NGMUSDNGM BIOPHARMACEUTICALS INC
$4.9M
CGENCOMPUGEN LTD
$4.7M
CBAYUSDCYMABAY THERAPEUTICS INC
$4.6M
NABRIVA THERAPEUTICS PLC
$4.6M
MEDICINES CO
$4.5M
GLOBAL CORD BLOOD CORPORATIO
$4.5M
CHIASMA INC
$4.5M
GAMIDA CELL LTD
$4.3M
BLUEBIRD BIO INC
$4.3M
HCATHEALTH CATALYST INC
$4.0M
MGNXMACROGENICS INC
$3.8M
LA JOLLA PHARMACEUTICAL CO
$3.7M
ICPTUSDINTERCEPT PHARMACEUTICALS IN
$3.6M
RESTORBIO INC
$3.5M
ARVNARVINAS INC
$3.2M
ACRSACLARIS THERAPEUTICS INC
$3.2M
TXG10X GENOMICS INC
$3.2M
FIVE PRIME THERAPEUTICS INC
$3.0M
CORREVIO PHARMA CORP
$2.4M
MYOVANT SCIENCES LTD
$2.3M
MERSANA THERAPEUTICS INC
$2.2M
PARATEK PHARMACEUTICALS INC
$1.9M
THERAVANCE BIOPHARMA INC
$1.4M
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC
$1.4M
RADIUS HEALTH INC
$1.4M
ADAPYADAPTIMMUNE THERAPEUTICS PLC
$1.3M
CRVSCORVUS PHARMACEUTICALS INC
$1.2M
CLVSEURCLOVIS ONCOLOGY INC
$1.0M
PACIRA BIOSCIENCES
$988K
DERMIRA INC
$844K
NVV1NOVAVAX INC
$816K
KLDOKALEIDO BIOSCIENCES INC
$753K
PROTEOSTASIS THERAPEUTICS IN
$338K
CVETUSDCOVETRUS INC
$246K
PreviousPage 2 of 2